IL6 and arthritic joint disease: IL-6, as well as TNF, IL-1β and PGE2, were reported to up-regulate the RANKL (receptor activator of NF-κB ligand) expression [33,34], which was an important prerequisite for osteoclast differentiation and arthritis [35,36,37].